Revolution Medicines
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12,775 | -118,021 | ||
EBITDA | -212,923 | -175,712 | -154,934 | -139,352 |
EBIT | -216,310 | -156,643 | -140,859 | |
Net Income | -194,569 | -156,288 | -133,233 | -116,003 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -139,512 | -133,939 | -130,566 | -163,727 |
Cash | 543,064 | 201,262 | 275,713 | 288,432 |
Basic Shares | 167,737 | 166,843 | 165,141 | 164,729 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $11,580 | $35,380 | $29,390 |
Gross Profit | 11,580 | 25,724 | 22,058 | |
EBITDA | -689,524 | -430,582 | -239,469 | -179,747 |
EBIT | -439,891 | -249,125 | -187,079 | |
Net Income | -600,093 | -436,367 | -248,705 | -179,771 |
Net Change In Cash | 0 | 11,580 | 35,380 | 29,390 |
Cost of Revenue | 4,882 | |||
Free Cash Flow | -567,744 | -358,301 | -235,217 | -153,708 |
Cash | 543,064 | 696,148 | 161,412 | 108,497 |
Basic Shares | 167,737 | 113,149 | 80,626 | 72,806 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.12 |
2024-09-30 | -$0.94 |
2024-06-30 | -$0.81 |
2024-03-31 | -$0.70 |
